Partial Peroxisome Proliferator-Activated Receptor Agonist Angiotensin Receptor Blockers
Explore this paper's citation graph
Summary
This review presents the experimental and preliminary clinical evidence supporting a promising role for partial PPAR-γ agonist ARBs in treating insulin resistance and the metabolic syndrome in patients with ischemic cerebrovascular disease.
- Type
- article
- Published
- 2008-06-17
- Cited by
- 32
- References
- 73
- OpenAlex
- https://openalex.org/W18560212
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:21613614
Keywords
Computer science
References
- Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
- Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis
- Effects of a potent and selective PPAR-alpha agonist in patients with atherogenic dyslipidemia or hypercholesterolemia: two randomized controlled trials.
- Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.
- Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Executive Summary
- Cerebral White Matter Hyperintensities on MRI: Current Concepts and Therapeutic Implications
- PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy?
- Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
- Challenges in improving prognosis and therapy: The Ongoing Telmisartan Alone and in Combination with Ramipril Global End point Trial Programme
- Cardiovascular morbidity and mortality associated with the metabolic syndrome.
- Prevalence of overweight and obesity in the United States, 1999-2004.
- Insulin and insulin resistance: impact on blood pressure and cardiovascular disease.
- Is the angiotensin ii type 2 receptor cerebroprotective?
- The Angiotensin II Type 2 (AT2) Receptor Promotes Axonal Regeneration in the Optic Nerve of Adult Rats
- Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin–angiotensin system
- Secondary Prevention of Macro Vascular Events in Patients With Type II Diabetes in the PROactive Study (PROspective Pioglitazone Clinical Trial and Macro Vascular Events): A Randomised Controlled Trial
- Effects of Pioglitazone in Patients With Type 2 Diabetes With or Without Previous Stroke: Results From PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04)
- Treating the metabolic syndrome: telmisartan as a peroxisome proliferator-activated receptor-gamma activator
- Atherosclerosis in Type 2 Diabetes Mellitus: The Role of Insulin Resistance
- Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.
Cited by
- Obesity Associated Pathology: Frequency, Character and Some Mechanisms of Formation
- Ассоциированная с ожирением патология: частота, характер и некоторые механизмы формирования
- Homocysteine and Hypertension in Diabetes: Does PPARγ Have a Regulatory Role?
- Cerebral Hemodynamics and Oxygen Metabolism in Patients with Moyamoya Syndrome Associated with Atherosclerotic Steno-Occlusive Arterial Lesions
- Insulin Resistance, Obesity, Metabolic Syndrome, and Lifestyle Modification
- Site-Specific Antioxidative Therapy for Prevention of Atherosclerosis and Cardiovascular Disease
- аССоЦИИРоваННаЯ С ожИРЕНИЕМ па ТоЛоГИЯ: ЧаСТоТ а, хаРаКТЕР И НЕКоТоРыЕ МЕхаНИЗМы ФоРМИРоваНИЯ
- Functional Genetic Variants of PPARγ and PPARα Encoding Peroxisome Proliferator-Activated Receptors and Susceptibility to Ischemic Stroke in Chinese Han Population
- obesity a ssociateD p athology: freQuency, character anD soMe MechanisMs of forMation
- The Effects of Telmisartan to Thickness of Aortic Tunica Media in 8% Sodium Chloride-Induced Wistar Rats (Rattus Norvegicus)
- Role of PPAR receptor in different diseases and their ligands: Physiological importance and clinical implications.
- Pioglitazone and PPAR-γ modulating treatment in hypertensive and type 2 diabetic patients after ischemic stroke: a national cohort study
- TLR-2-mediated metabolic reprogramming participates in polyene phosphatidylcholine-mediated inhibition of M1 macrophage polarization
- Clinical Evidence of Antidepressant Effects of Insulin and Anti-Hyperglycemic Agents and Implications for the Pathophysiology of Depression—A Literature Review
- Anti-Diabetic Effect of Telmisartan Through its Partial PPARγ-Agonistic Activity
- Hypertension in the Dog and Cat
- The impact of early pregnancy metabolic disorders on pregnancy outcome and the specific mechanism
- SIRT1 alleviates insulin resistance and respiratory distress in late preterm rats by activating QKI5-mediated PPARγ/PI3K/AKT pathway
- Targeting Peroxisome Proliferator-Activated Receptor-β/δ, Reactive Oxygen Species and Redox Signaling with Phytocompounds for Cancer Therapy
- PPARs in atherosclerosis: The spatial and temporal features from mechanism to druggable targets
Related papers
No related papers recorded.